FDA NDC Directory · JSON-LD · Markdown
NDC 69097-032 · HUMAN PRESCRIPTION DRUG · CAPSULE
| Labeler / Manufacturer | Cipla USA Inc. |
|---|---|
| Marketing category | New Drug Application (innovator) · App NDA218922 |
| Dosage form / route | CAPSULE · ORAL |
| Active ingredients | NILOTINIB (200 mg/1) |
| Marketing started | 20250618 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).